CVS Caremark To Present At The Morgan Stanley 2014 Global Healthcare Conference

Loading...
Loading...

WOONSOCKET, R.I., Aug. 29, 2014 /PRNewswire/ -- CVS Caremark Corporation CVS today announced that Larry Merlo, the company's president and chief executive officer, will be making a presentation to investors at the Morgan Stanley 2014 Global Healthcare Conference on September 9, 2014. He is scheduled to present at approximately 8:35 a.m. (EDT).

An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the website for a one-year period following the presentation.

About CVS Caremark

CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,700 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 64 million plan members; and its retail health clinic system, the largest in the nation with more than 860 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications. Find more information about how CVS Caremark is reinventing pharmacy for better health at http://info.cvscaremark.com.

Logo - http://photos.prnewswire.com/prnh/20090226/NE75914LOGO

SOURCE CVS Caremark Corporation

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...